Univest
Univest
  • Markets

Pramodini Medicare Initial Public Offering Closes Today 14 August 2026: Last Chance to Apply for BSE SME Healthcare Company IPO

  • August 14, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Pramodini Medicare Initial Public Offering Closes Today 14 August 2026: Last Chance to Apply for BSE SME Healthcare Company IPO

Pramodini Medicare initial public offering: LAST DAY 14 Aug 2026. Sub 12-14 Aug. BSE SME. Healthcare and pharma. Apply before market close today via ASBA or UPI.

Quick Answer

Pramodini Medicare’s initial public offering subscription window closes today, 14 August 2026 — this is it, the last session. The healthcare and pharmaceuticals company is listing on BSE SME, and all bids must be in before market close today. After today’s session ends, the subscription shuts and there’s no way to apply. Get your ASBA or UPI bid in through your broker app before the market closes.

The Pramodini Medicare initial public offering is open for subscription today, 14 August 2026. Today is the last day to apply. Once today’s market session closes, the subscription window shuts permanently. Pramodini Medicare is a Healthcare and Pharmaceuticals company seeking to list on BSE SME, and the full bidding window runs from 12 August 2026 to 14 August 2026. If you’re planning to apply, you’ll need to go through ASBA or UPI on any SEBI-registered broker platform before 14 August 2026 closes out the window.

Keep in mind that 14 August is the last trading session before the three-day Independence Day long weekend — markets are closed on 15 August, and 16-17 August are Saturday and Sunday. Any application submitted today for Pramodini Medicare initial public offering will be processed, but for IPOs closing today (14 August), this is genuinely your final window before the market shuts for the holiday.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Is the Pramodini Medicare initial public offering?
  • How to Apply for the Pramodini Medicare initial public offering
  • Pramodini Medicare initial public offering: Grey Market Premium and Subscription Status
  • Key Risks Before You Apply
  • Conclusion
  • Frequently Asked Questions
    • What is the Pramodini Medicare initial public offering?
    • When does the Pramodini Medicare initial public offering close?
    • What is the grey market premium for the Pramodini Medicare initial public offering?
    • How do I apply for the Pramodini Medicare initial public offering?
    • What investor categories can apply for the Pramodini Medicare initial public offering?
    • What are the key risks of the Pramodini Medicare initial public offering?
    • When will Pramodini Medicare initial public offering allotment be announced and how do I check it?

What Is the Pramodini Medicare initial public offering?

Pramodini Medicare is a healthcare and pharmaceutical company providing medical products and healthcare services across domestic markets. The Pramodini Medicare initial public offering will allow the company to access public capital for the first time — typically earmarked for business expansion, working capital, and general corporate purposes as laid out in the DRHP filed with SEBI. Investors evaluating the Pramodini Medicare initial public offering should pull the prospectus from the SEBI EDGAR portal and review the financial statements, risk factors, and promoter background before committing capital.

The Healthcare and Pharmaceuticals sector that Pramodini Medicare operates in has seen growing investor interest in India’s primary market, with several sector peers already listed on exchanges. Whether the Pramodini Medicare initial public offering valuation is attractive relative to those peers is a calculation worth doing before applying. The issue price and lot size details are in the prospectus.

Detail Information
Company Pramodini Medicare
Sector Healthcare and Pharmaceuticals
Exchange BSE SME
Subscription Opens 12 August 2026
Subscription Closes 14 August 2026
Today (14 Aug) Last Day
Apply Via ASBA or UPI
GMP Not published by Univest — check third-party tracker platforms

How to Apply for the Pramodini Medicare initial public offering

Applying for the Pramodini Medicare initial public offering is straightforward: open your broker app or bank’s net banking, find the Pramodini Medicare IPO in the current issues section, select your lot size, and bid at the cutoff price. For retail investors, bidding at cutoff means you’ll pay whatever the final allotment price is, which maximises your chances of getting shares. Once you submit, approve the UPI mandate promptly or your ASBA block will be placed automatically by your bank.

A few things to check before hitting submit: confirm your demat is KYC-verified, your bank account has sufficient available balance (blocked for the bid amount until allotment), and your UPI ID is active. For Pramodini Medicare initial public offering, applications close on 14 August 2026 — and on closing days, UPI platforms can experience traffic spikes, so applying a few hours early rather than right at market close is the safer approach.

Track the Pramodini Medicare IPO and Full Subscription Calendar on Univest

Pramodini Medicare initial public offering: Grey Market Premium and Subscription Status

If you’ve been tracking grey market premium for the Pramodini Medicare initial public offering, keep this in mind: Univest doesn’t publish GMP figures for any initial public offering, and that’s deliberate. GMP is collected informally, is unregulated, and can swing by several percentage points within a single day depending on which platform you check. It’s not endorsed by SEBI, NSE, or BSE, and it’s not a reliable predictor of actual listing performance. For live GMP data on the Pramodini Medicare initial public offering, third-party tracker platforms carry it — just don’t treat those numbers as investment signals.

What gives a cleaner read on investor demand for the Pramodini Medicare initial public offering is the day-wise subscription data published on BSE and NSE. Checking how the retail, NII, and QIB categories are filling up gives you a demand picture that’s actually regulated and verifiable. Strong QIB participation in particular is generally a positive demand signal for the Pramodini Medicare initial public offering.

Key Risks Before You Apply

Three risks worth flagging for the Pramodini Medicare initial public offering: First, post-listing liquidity. Smaller exchange listings — especially BSE SME — typically have lower daily trading volumes than mainboard stocks, which can make exiting your position harder than it looks in the first few sessions. Second, sector-specific risks in the Healthcare and Pharmaceuticals space: regulatory changes, competition from larger players, or input cost pressures can hurt earnings after listing. Third, valuation risk — IPOs sometimes price aggressively, and a stock that lists well can still underperform if earnings don’t follow through. Read the risk factors section in the Pramodini Medicare initial public offering prospectus before you commit.

Download the Univest iOS App or Univest Android App to track the Pramodini Medicare initial public offering and full IPO calendar from Univest.

Conclusion

The Pramodini Medicare initial public offering is open from 12 August 2026 to 14 August 2026, with Last Day of the subscription window underway on 14 August 2026. Pramodini Medicare is a Healthcare and Pharmaceuticals company listing on BSE SME. For investors who’ve evaluated the business and want to participate, apply through ASBA or UPI before 14 August 2026. Read the DRHP, assess the valuation, and get guidance from a SEBI-registered financial advisor before investing. Allotment results follow the closing of the subscription on 14 August 2026.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the Pramodini Medicare initial public offering?

Ans. The Pramodini Medicare initial public offering is a public equity offering by Pramodini Medicare, a Healthcare and Pharmaceuticals company seeking to list on BSE SME. The subscription is open from 12 August 2026 to 14 August 2026. Investors can apply through ASBA or a UPI-linked demat account on any SEBI-registered broker platform. Check the SEBI EDGAR portal for the official prospectus and complete details before applying.

When does the Pramodini Medicare initial public offering close?

Ans. The Pramodini Medicare initial public offering subscription closes on 14 August 2026. Today is the last day to apply. Applications must be submitted through ASBA or UPI before the close of market hours on 14 August 2026. Bids submitted after market close on the final day will not be accepted. If you’re applying via UPI, approve the mandate request as soon as it appears to avoid last-minute technical delays.

What is the grey market premium for the Pramodini Medicare initial public offering?

Ans. Univest does not publish grey market premium figures for any initial public offering. Grey market premium is an unofficial and unregulated indicator collected informally outside the stock exchanges. It is not published, verified or endorsed by SEBI, NSE or BSE, can vary widely between trackers, and is not always accurate. For GMP data, refer to third-party tracker platforms and treat those numbers as sentiment signals, not investment guidance.

How do I apply for the Pramodini Medicare initial public offering?

Ans. Log into your broker app or bank’s net banking, navigate to the current IPO section, and search for Pramodini Medicare. Select the number of lots, bid at the cutoff price (retail investors applying at cutoff get the final allotted price automatically), and confirm the ASBA block or UPI mandate. Ensure your demat is KYC-verified and your bank account supports ASBA before applying for the Pramodini Medicare initial public offering.

What investor categories can apply for the Pramodini Medicare initial public offering?

Ans. The Pramodini Medicare initial public offering is open to Retail Individual Investors, Non-Institutional Investors, and Qualified Institutional Buyers in their designated quota categories. Retail investors can bid up to Rs 2 lakh per application. The minimum lot size and price band are available in the prospectus filed on the SEBI EDGAR portal.

What are the key risks of the Pramodini Medicare initial public offering?

Ans. Key risks of the Pramodini Medicare initial public offering include limited post-listing liquidity typical of smaller exchange listings, sector-specific competitive and regulatory challenges in the Healthcare and Pharmaceuticals space, valuation uncertainty at the issue price relative to listed peers, and general market risk. Listing gains are not guaranteed. Read the DRHP risk factors thoroughly and consult a SEBI-registered financial advisor before applying.

When will Pramodini Medicare initial public offering allotment be announced and how do I check it?

Ans. Allotment for the Pramodini Medicare initial public offering is typically announced within 6 business days after 14 August 2026. You can check your allotment status on BSE at bseindia.com or NSE at nseindia.com using your PAN or application number. Refunds for unsuccessful applicants and share credits for successful ones follow the allotment date. The listing date will be announced by the company and lead managers after allotment is completed.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply